ASRS
OCUL icon

Arizona State Retirement System’s Ocular Therapeutix OCUL Stock Holding History

Arizona State Retirement System’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$372K Sell
43,889
-321
-0.7% -$3.06K ﹤0.01% 1623
2025
Q4 		$537K Buy
44,210
+13,571
+44% +$165K ﹤0.01% 1433
2025
Q3 		$358K Buy
30,639
+474
+2% +$5.67K ﹤0.01% 1694
2025
Q2 		$280K Buy
30,165
+3,126
+12% +$24.5K ﹤0.01% 1761
2025
Q1 		$198K Sell
27,039
-82
-0.3% -$630 ﹤0.01% 1894
2024
Q4 		$232K Sell
27,121
-1,869
-6% -$18.2K ﹤0.01% 1885
2024
Q3 		$252K Buy
28,990
+839
+3% +$6.92K ﹤0.01% 1854
2024
Q2 		$193K Buy
+28,151
New +$174K ﹤0.01% 1912
2022
Q2 		– Sell
-19,673
Closed -$97K – 2282
2022
Q1 		$97K Buy
19,673
+92
+0.5% +$510 ﹤0.01% 2160
2021
Q4 		$136K Buy
19,581
+1,917
+11% +$14.9K ﹤0.01% 2176
2021
Q3 		$177K Buy
17,664
+265
+2% +$2.98K ﹤0.01% 2098
2021
Q2 		$247K Sell
17,399
-266
-2% -$4.04K ﹤0.01% 1985
2021
Q1 		$290K Buy
17,665
+82
+0.5% +$1.58K ﹤0.01% 1830
2020
Q4 		$364K Buy
+17,583
New +$261K ﹤0.01% 1631

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Arizona State Retirement System's OCUL Position: Q1 2026 in Review

Arizona State Retirement System reduced its Ocular Therapeutix (OCUL) stake by 0.73% in Q1 2026, selling an estimated $3.06K and leaving 43,889 shares worth $372K. The position accounts for ﹤0.01% of the portfolio, ranked #1623.

Arizona State Retirement System first reported a position in OCUL in Q4 2020 and has held it in 14 quarters since. The position peaked at $537K in Q4 2025. 269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

  • Arizona State Retirement System held 43,889 shares of Ocular Therapeutix worth $372K as of Q1 2026.
  • Arizona State Retirement System sold 321 Ocular Therapeutix shares in Q1 2026, an estimated $3.06K.
  • Ocular Therapeutix made up ﹤0.01% of Arizona State Retirement System's portfolio in Q1 2026, its #1623 holding.
  • Arizona State Retirement System first reported a position in Ocular Therapeutix in Q4 2020 and has held it in 14 quarters since.
  • Arizona State Retirement System's Ocular Therapeutix position peaked at $537K in Q4 2025.
  • 269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on Arizona State Retirement System's 13F filing for Q1 2026, filed 1 May 2026.